[(2R,3R,4S,5R,6S)-3-hydroxy-4,5,6-tris(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
Structure Info
- Chemspace ID
- CSSB00159262964 (In-Stock Building Blocks)
- MFCD
- MFCD31693264, MFCD12605904
- IUPAC Name
- [(2R,3R,4S,5R,6S)-3-hydroxy-4,5,6-tris(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
- Mol formula
- C34H28O22
- Mol weight
- 789 Da
- Catalog Number(s)
- 329428, A1176784, AA0054YP, AC39613, ACYXKV089, AG00551H, AKOS040760170, AR0055QH, ArZ-UP478667, BBP05354, BD01115703, BUP00587, CFN00447, CSC159262964, E87174, EC005779, HY-111832, M29063, MS-31445, MT46232, NP-003686, ST0056I9, TN1160, TX005675, Y1239751, Y4285907, ZX-CY000443, ZXC176697
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.41
- Heavy atoms count
- 56
- Rotatable bond count
- 13
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.176
- Polar surface area (Å)
- 377
- Hydrogen bond acceptors count
- 18
- Hydrogen bond donors count
- 13
![Chemical structure of [(2R,3R,4S,5R,6S)-3-hydroxy-4,5,6-tris(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate (C34H28O22) - CSSB00159262964](/st/structure/200/9f7777c607b0f4305cf5d513edaa2853/O%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528COC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540H%255D1OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png "C34H28O22")
- Zoom the structure
- CSSB00159262964
Items Overall 53 items from 15 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 5 mg | 126.00 | |
Description: Name:(2S,3R,4S,5R,6R)-5-Hydroxy-6-(((3,4,5-trihydroxybenzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4-triyl tris(3,4,5-trihydroxybenzoate); CAS: 79886-50-3 | ||||||
| Astatech Inc | 2 days | United States To: | 95 | 1 mg | 68.20 | |
| Astatech Inc | 2 days | United States To: | 95 | 5 mg | 138.60 | |
| Astatech Inc | 2 days | United States To: | 95 | 10 mg | 177.10 | |
Description: 1,2,3,6-TETRAGALLOYLGLUCOSE; CAS: 79886-50-3 | ||||||
| 1st Scientific CN | 3 days | China To: | 98 | 1 mg | 50.60 | |
| 1st Scientific CN | 3 days | China To: | 98 | 5 mg | 101.20 | |
| 1st Scientific CN | 3 days | China To: | 98 | 10 mg | 193.60 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 50.60 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 mg | 101.20 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 10 mg | 193.60 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 1 mg | 62.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 5 mg | 126.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 10 mg | 161.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 25 mg | 306.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 50 mg | 490.00 | |
Description: Name:(2S,3R,4S,5R,6R)-5-Hydroxy-6-(((3,4,5-trihydroxybenzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4-triyl tris(3,4,5-trihydroxybenzoate); CAS: 79886-50-3 | ||||||
| AiFChem CN | 10 days | China To: | 98 | 1 mg | 58.00 | |
| AiFChem CN | 10 days | China To: | 98 | 5 mg | 117.00 | |
| AiFChem CN | 10 days | China To: | 98 | 10 mg | 149.00 | |
| AiFChem CN | 10 days | China To: | 98 | 25 mg | 283.00 | |
| AiFChem CN | 10 days | China To: | 98 | 50 mg | 453.00 | |
Description: (2S,3R,4S,5R,6R)-5-Hydroxy-6-(((3,4,5-trihydroxybenzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4-triyl tris(3,4,5-trihydroxybenzoate); Hazard statement: H302, H315, H319; CAS: 79886-50-3 | ||||||
| Angene International Limited | 10 days | China To: | 90 | 1 mg | 213.30 | |
| Angene International Limited | 10 days | China To: | 90 | 20 mg | 307.80 | |
| Angene International Limited | 10 days | China To: | 90 | 50 mg | 639.90 | |
| Angene International Limited | 10 days | China To: | 90 | 100 mg | 1,110.60 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| Ambeed CN | 12 days | China To: | 98 | 1 mg | 55.80 | |
| Ambeed CN | 12 days | China To: | 98 | 5 mg | 113.40 | |
| Ambeed CN | 12 days | China To: | 98 | 10 mg | 144.90 | |
| Ambeed CN | 12 days | China To: | 98 | 25 mg | 275.40 | |
| Ambeed CN | 12 days | China To: | 98 | 50 mg | 441.00 | |
Description: Name: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 98 | 1 mg | 55.80 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 5 mg | 113.40 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 10 mg | 144.90 | |
Description: Name: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 1 mg | 60.50 | |
| AA BLOCKS | 12 days | United States To: | 98 | 5 mg | 122.10 | |
| AA BLOCKS | 12 days | United States To: | 98 | 10 mg | 156.20 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 71.30 | |
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 144.90 | |
| A2B Chem | 12 days | United States To: | 98 | 10 mg | 238.05 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 20 mg | 343.85 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 50 mg | 715.30 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 100 mg | 1,242.00 | |
| eNovation CN | 20 days | China To: | 98 | 1 mg | 74.75 | |
| eNovation CN | 20 days | China To: | 98 | 5 mg | 120.75 | |
| eNovation CN | 20 days | China To: | 98 | 10 mg | 138.00 | |
| eNovation CN | 20 days | China To: | 98 | 25 mg | 230.00 | |
| eNovation CN | 20 days | China To: | 98 | 50 mg | 345.00 | |
Description: (2S,3R,4S,5R,6R)-5-Hydroxy-6-(((3,4,5-trihydroxybenzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4-triyl tris(3,4,5-trihydroxybenzoate); CAS: 79886-50-3 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 90 | 1 mg | 358.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 20 mg | 481.80 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 50 mg | 1,002.10 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 100 mg | 1,738.00 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 50.60 | |
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 102.30 | |
| 10X CHEM | TBD | United States To: | 98 | 10 mg | 176.00 | |
Description: 1,2,3,6-Tetragalloylglucose; CAS: 79886-50-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of [(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate - CSSB00159262903](/st/structure/200/ecf4bff498892522f5cc9d61fb902355/OC1%253DCC%2528%253DCC%2528O%2529%253DC1O%2529C%2528%253DO%2529OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540%2540H%255D1OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png)
![Chemical structure of 2-[(4R,5S,7R,25S,26R,29S,30S,31S)-13,14,15,18,19,20,31,35,36-nonahydroxy-2,10,23,28,32-pentaoxo-5-(3,4,5-trihydroxybenzoyloxy)-3,6,9,24,27,33-hexaoxaheptacyclo[28.7.1.0⁴,²⁵.0⁷,²⁶.0¹¹,¹⁶.0¹⁷,²².0³⁴,³⁸]octatriaconta-1(37),11,13,15,17,19,21,34(38),35-nonaen-29-yl]acetic acid - CSSB02495363065](/st/structure/200/a3769ba3c725a2418873aaafe3b8de62/O%255BC%2540H%255D1%255BC%2540H%255D2%255BC%2540H%255D%2528CC%2528O%2529%253DO%2529C%2528%253DO%2529O%255BC%2540%2540H%255D3%255BC%2540H%255D4COC%2528%253DO%2529C5%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC5C5%253DC%2528O%2529C%2528O%2529%253DC%2528O%2529C%253DC5C%2528%253DO%2529O%255BC%2540%2540H%255D3%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C3%253DCC%2528O%2529%253DC%2528O%2529C%2528OC1%253DO%2529%253DC23%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1%2529O4.png)
![Chemical structure of 2-[(4R,5S,7R,8R,11S,12S,13S,21S)-13,17,18-trihydroxy-2,10,14-trioxo-5,21-bis(3,4,5-trihydroxybenzoyloxy)-7-[(3,4,5-trihydroxybenzoyloxy)methyl]-3,6,9,15-tetraoxatetracyclo[10.7.1.1⁴,⁸.0¹⁶,²⁰]henicosa-1(19),16(20),17-trien-11-yl]acetic acid - CSSB02125552593](/st/structure/200/f8ee374cc13336238c99f7f60193ec18/O%255BC%2540H%255D1%255BC%2540H%255D2%255BC%2540H%255D%2528CC%2528O%2529%253DO%2529C%2528%253DO%2529O%255BC%2540%2540H%255D3%255BC%2540%2540H%255D%2528COC%2528%253DO%2529C4%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC4%2529O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C4%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC4%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C4%253DCC%2528O%2529%253DC%2528O%2529C%2528OC1%253DO%2529%253DC24%2529%255BC%2540H%255D3OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png)
![Chemical structure of (1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-undecahydroxy-2,5,10,23,31-pentaoxo-6,9,24,27,30,40-hexaoxaoctacyclo[34.3.1.0⁴,³⁸.0⁷,²⁶.0⁸,²⁹.0¹¹,¹⁶.0¹⁷,²².0³²,³⁷]tetraconta-3,11,13,15,17,19,21,32(37),33,35-decaen-28-yl 3,4,5-trihydroxybenzoate - CSSB02125553714](/st/structure/200/b5eb4237e04492add7f946b940be1ae7/OC1%253DCC%2528%253DCC%2528O%2529%253DC1O%2529C%2528%253DO%2529O%255BC%2540%2540H%255D1O%255BC%2540%2540H%255D2COC%2528%253DO%2529C3%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC3C3%253DC%2528O%2529C%2528O%2529%253DC%2528O%2529C%253DC3C%2528%253DO%2529O%255BC%2540H%255D3%255BC%2540%2540H%255D2OC%2528%253DO%2529C2%253DCC%2528%253DO%2529%255BC%2540%255D4%2528O%2529OC5%253DC%2528O%2529C%2528O%2529%253DCC%2528%253DC5%255BC%2540H%255D2C4%2528O%2529O%2529C%2528%253DO%2529O%255BC%2540%2540H%255D13.png)
![Chemical structure of 2,3-dihydroxy-5-({[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoyloxy]oxan-2-yl]methoxy}carbonyl)phenyl 3,4,5-trihydroxybenzoate - CSSB00159262775](/st/structure/200/a21e921aa89b1a1ec7197cab24a6fc90/OC1%253DCC%2528%253DCC%2528O%2529%253DC1O%2529C%2528%253DO%2529OC1%253DCC%2528%253DCC%2528O%2529%253DC1O%2529C%2528%253DO%2529OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528OC%2528%253DO%2529C3%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC3%2529%253DC2%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528OC%2528%253DO%2529C3%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC3%2529%253DC2%2529%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528OC%2528%253DO%2529C3%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC3%2529%253DC2%2529%255BC%2540%2540H%255D1OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%253DC1.png)
![Chemical structure of (2S,3R,4S,5R,6R)-3,4,5-tris[3,4,5-tris(benzyloxy)benzoyloxy]-6-{[3,4,5-tris(benzyloxy)benzoyloxy]methyl}oxan-2-yl 3,4,5-tris(benzyloxy)benzoate - CSSB07094603887](/st/structure/200/c698c3f3382498d56bf0c54c8b067774/O%253DC%2528OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529c2cc%2528OCc3ccccc3%2529c%2528OCc3ccccc3%2529c%2528OCc3ccccc3%2529c2%2529%255BC%2540H%255D%2528OC%2528%253DO%2529c2cc%2528OCc3ccccc3%2529c%2528OCc3ccccc3%2529c%2528OCc3ccccc3%2529c2%2529%255BC%2540%2540H%255D%2528OC%2528%253DO%2529c2cc%2528OCc3ccccc3%2529c%2528OCc3ccccc3%2529c%2528OCc3ccccc3%2529c2%2529%255BC%2540%2540H%255D1OC%2528%253DO%2529c1cc%2528OCc2ccccc2%2529c%2528OCc2ccccc2%2529c%2528OCc2ccccc2%2529c1%2529c1cc%2528OCc2ccccc2%2529c%2528OCc2ccccc2%2529c%2528OCc2ccccc2%2529c1.png)
Similarity Analogs
![Chemical structure of [(2R,3R,4S,5R,6S)-3,5-dihydroxy-4,6-bis(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate - CSSB00159261965](/st/structure/200/0767d9c04b522991b61199110cc8f4bd/O%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528COC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D1OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png)
![Chemical structure of (2S,3R,4S,5S,6R)-4,5-dihydroxy-2-(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate - CSSB00159279087](/st/structure/200/eedaae29e231e6ef891804c3fa83287d/O%255BC%2540H%255D1%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529O%255BC%2540%2540H%255D1COC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png)
![Chemical structure of (2S,3R,4R,5R,6R)-3-hydroxy-4,5-bis(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-2-yl 3,4,5-trihydroxybenzoate - CSSB00159280870](/st/structure/200/4df6872c261b090a2bea8e662c9e2ff1/O%255BC%2540H%255D1%255BC%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529O%255BC%2540H%255D%2528COC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540%2540H%255D1OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png)
![Chemical structure of [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate - CSSB00159243702](/st/structure/200/76e8e1dc91d85cd865a91c7ce9ae4899/O%255BC%2540H%255D1%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528COC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529O%255BC%2540%2540H%255D%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of [3,4,5,6-tetrakis(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate - CSSB03437848972](/st/structure/200/01a659913d1cef41b75a9d835e9413ea/OC1%253DCC%2528%253DCC%2528O%2529%253DC1O%2529C%2528%253DO%2529OCC1OC%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529C%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529C%2528OC%2528%253DO%2529C2%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC2%2529C1OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1.png)
![Chemical structure of (1S,19R,21S,22R,23R)-6,7,8,11,12,13,22,23-octahydroxy-3,16-dioxo-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10,12,14-hexaen-21-yl 3,4,5-trihydroxybenzoate - CSSB00116207018](/st/structure/200/385ad172e255cb3bcc836077139f14bc/O%255BC%2540%2540H%255D1%255BC%2540H%255D2COC%2528%253DO%2529C3%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC3C3%253DC%2528O%2529C%2528O%2529%253DC%2528O%2529C%253DC3C%2528%253DO%2529O%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528OC%2528%253DO%2529C1%253DCC%2528O%2529%253DC%2528O%2529C%2528O%2529%253DC1%2529O2.png)
